Winton Group’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-379,084
| Closed | -$5.83M | – | 1179 |
|
|
2025
Q4 | $5.83M | Buy |
379,084
+267,897
| +241% | +$2.95M | 0.2% | 158 |
|
|
2025
Q3 | $1.1M | Buy |
111,187
+53,607
| +93% | +$558K | 0.04% | 420 |
|
|
2025
Q2 | $571K | Sell |
57,580
-19,226
| -25% | -$203K | 0.03% | 558 |
|
|
2025
Q1 | $996K | Sell |
76,806
-350,008
| -82% | -$4.63M | 0.06% | 425 |
|
|
2024
Q4 | $5.45M | Buy |
426,814
+329,579
| +339% | +$3.99M | 0.36% | 78 |
|
|
2024
Q3 | $1.08M | Buy |
97,235
+14,832
| +18% | +$163K | 0.08% | 258 |
|
|
2024
Q2 | $925K | Buy |
82,403
+7,025
| +9% | +$81.8K | 0.06% | 292 |
|
|
2024
Q1 | $935K | Buy |
75,378
+41,621
| +123% | +$543K | 0.07% | 304 |
|
|
2023
Q4 | $472K | Sell |
33,757
-1,200
| -3% | -$16.7K | 0.03% | 348 |
|
|
2023
Q3 | $516K | Sell |
34,957
-11,143
| -24% | -$157K | 0.04% | 233 |
|
|
2023
Q2 | $596K | Sell |
46,100
-65,084
| -59% | -$742K | 0.05% | 262 |
|
|
2023
Q1 | $1.09M | Buy |
111,184
+17,148
| +18% | +$183K | 0.07% | 415 |
|
|
2022
Q4 | $1M | Buy |
94,036
+11,544
| +14% | +$134K | 0.07% | 406 |
|
|
2022
Q3 | $861K | Buy |
82,492
+1,656
| +2% | +$21.6K | 0.06% | 460 |
|
|
2022
Q2 | $1.02M | Buy |
80,836
+40,047
| +98% | +$425K | 0.05% | 479 |
|
|
2022
Q1 | $442K | Buy |
40,789
+6,095
| +18% | +$74K | 0.02% | 719 |
|
|
2021
Q4 | $488K | Buy |
+34,694
| New | +$571K | 0.03% | 681 |
|
|
2018
Q2 | – | Sell |
-10,019
| Closed | -$199K | – | 1050 |
|
|
2018
Q1 | $199K | Buy |
+10,019
| New | +$173K | 0.01% | 1109 |
|
Other funds holding DVAX
Winton Group's DVAX Position: Q1 2026 in Review
Winton Group sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 379,084 shares — an estimated $5.83M sold.
Winton Group first reported a position in DVAX in Q1 2018 and held it in 18 quarters. The position peaked at $5.83M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Winton Group reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Winton Group sold 379,084 Dynavax Technologies shares in Q1 2026, an estimated $5.83M.
- Winton Group first reported a position in Dynavax Technologies in Q1 2018 and held it in 18 quarters.
- Winton Group's Dynavax Technologies position peaked at $5.83M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Winton Group's 13F filing for Q1 2026, filed 12 May 2026.